The Commissioner of Food and Drugs (the Commissioner) is denying requests for a hearing and issuing an order withdrawing approval of abbreviated new drug applications (ANDAs) for certain prescription laxatives with the active ingredient polyethylene glycol 3350 (PEG 3350), listed in this document, because the drug products are misbranded under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Document
Prescription Polyethylene Glycol 3350; Denial of a Hearing and Order Withdrawing Approval of Abbreviated New Drug Applications
The Commissioner of Food and Drugs (the Commissioner) is denying requests for a hearing and issuing an order withdrawing approval of abbreviated new drug applications (ANDAs) fo...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 13994
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Prescription Polyethylene Glycol 3350; Denial of a Hearing and Order Withdrawing Approval of Abbreviated New Drug Applications,” thefederalregister.org (April 2, 2018), https://thefederalregister.org/documents/2018-06537/prescription-polyethylene-glycol-3350-denial-of-a-hearing-and-order-withdrawing-approval-of-abbreviated-new-drug-applica.